Submit your Disease claim details for a free, no obligation case review.
Get Started:
disease dvtWhen a person develops the symptoms of pulmonary embolism, it is vital to seek medical treatment immediately. This condition is so dangerous that approximately ten percent of all patients die within 30 to 60 minutes after developing the symptoms of pulmonary embolism. There are certain patient populations who are at a greater risk of developing the symptoms of pulmonary embolism, and should therefore be aware of the signs and symptoms of this life threatening condition.
Pulmonary embolism occurs when a blood clot travels to the lungs and blocks an artery. Pulmonary embolism is the most common complication of deep vein thrombosis (DVT) whereby a blood clot forms in the deep vein of the leg or other body part. When learning about the symptoms of pulmonary embolism, it is also important for patients to know the symptoms of DVT. With prompt and adequate treatment a patient with DVT can typically avoid complications that cause the symptoms of pulmonary embolism.
The symptoms of pulmonary embolism can include any, or all, of the following:
When a person experiences any of these symptoms of pulmonary embolism, they should seek medical attention immediately.
In many cases, the symptoms of pulmonary embolism follow the symptoms and/or diagnosis of DVT. In many cases, a person will experience symptoms and signs of DVT. Sometimes these blood clots are silent and it is not until the symptoms of pulmonary embolism appear that a person learns they suffered DVT. When they do appear, symptoms of DVT can include pain, swelling, tenderness, warmth, and redness of one leg.
There are many factors that increase a person''s risk of developing the symptoms of pulmonary embolism. Medications that contain the hormone estrogen have been known to increase the risks that a patient will develop symptoms of pulmonary embolism. The risk is considered low enough that the benefits of oral contraceptives and HRT have outweighed their risks. Recent reports have indicated that use of the Ortho Evra contraceptive patch can triple a person''s risk of developing the fatal symptoms of pulmonary embolism.
Clinical trials conducted before Ortho Evra was approved in 2001 discovered two cases of pulmonary embolism in participants using the patch. At that time the FDA expressed concern over the blood clot and related risks associated with the patch. Today it seems that several young and healthy women using the patch have developed the symptoms of pulmonary embolism and died of complications. It is still unknown the exact risk between the contraceptive patch and the risk of developing the symptoms of pulmonary embolism.
If you or a loved one has suffered serious injury or death while using Ortho Evra, please contact an experienced attorney who can evaluate your case to determine and protect your legal rights and options.